Keyphrases
Messenger RNA (mRNA)
100%
Delta Variant
100%
SARS-CoV-2 Omicron
100%
Omicron Variant
100%
SARS-CoV-2 Delta
100%
RNA Vaccination
100%
Vaccination
40%
CD8+ T Cells
20%
Enhanced Protection
20%
Specific Immunity
20%
Messenger RNA Vaccine
20%
SARS-CoV-2 Variants of Concern
20%
Lung
10%
Broad Protection
10%
Hamster Model
10%
Effective Approach
10%
Antigen-specific
10%
Upper Respiratory Tract
10%
COVID-19
10%
Modified nucleosides
10%
Spike Protein
10%
Viral nucleoprotein
10%
COVID-19 Vaccine
10%
Viral Spike Protein
10%
SARS-CoV-2 Variants
10%
Robust Control
10%
Immune Analysis
10%
Delta Strain
10%
Omicron Strain
10%
Immunology and Microbiology
Virus Nucleocapsid
100%
Spike
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Omicron Coronavirus Variant
100%
Adaptive Immune System
40%
Cytotoxic T-Cell
40%
RNA Vaccine
40%
Nucleoprotein
20%
Antigen Specificity
20%
Hamster Model
20%
Immunity
20%
Upper Respiratory Tract
20%
T Cell Depletion
20%
Virus Spike
20%
COVID-19
20%
Medicine and Dentistry
Virus Nucleocapsid
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Omicron Coronavirus Variant
100%
RNA Immunization
100%
Messenger RNA
100%
Adaptive Immunity
16%
Cytotoxic T-Cell
16%
RNA Vaccine
16%
Antigen Specificity
8%
Immunity
8%
Upper Respiratory Tract
8%
Protein S
8%
Nucleoside
8%
Virus Nucleoprotein
8%
COVID-19 Vaccine
8%
Virus Spike Protein
8%
Lung
8%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Virus Nucleocapsid
100%
Spike
100%
Messenger RNA
100%
Adaptive Immunity
16%
CD8
16%
Nucleoprotein
8%
Nucleoside
8%
T Cell
8%
Immunity
8%
Hamster Model
8%
Protein S
8%
Antigen Specificity
8%
T Cell Depletion
8%
Virus Spike
8%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Delta Variant
100%
Messenger RNA
100%
RNA Vaccine
16%
CD8 Antigen
16%
Hamster Model
8%
Respiratory Tract
8%
Nucleoside
8%
Protein S
8%
Virus Nucleoprotein
8%
Virus Spike Protein
8%
COVID-19 Vaccine
8%